Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Two-Pore-Domain K+ Channels Are a Novel Target for the Anesthetic Gases Xenon, Nitrous Oxide, and Cyclopropane

Marco Gruss, Trevor J. Bushell, Damian P. Bright, William R. Lieb, Alistair Mathie and Nicholas P. Franks
Molecular Pharmacology February 2004, 65 (2) 443-452; DOI: https://doi.org/10.1124/mol.65.2.443
Marco Gruss
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Trevor J. Bushell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Damian P. Bright
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William R. Lieb
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alistair Mathie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas P. Franks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 65 no. 2 443-452
DOI 
https://doi.org/10.1124/mol.65.2.443
PubMed 
14742687

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received September 15, 2003
  • Accepted October 30, 2003
  • Published online January 22, 2004.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Marco Gruss,
  2. Trevor J. Bushell1,
  3. Damian P. Bright,
  4. William R. Lieb,
  5. Alistair Mathie and
  6. Nicholas P. Franks
  1. Biophysics Section, Department of Biological Sciences, The Blackett Laboratory, Imperial College London, United Kingdom
  1. Address correspondence to:
    Nicholas P. Franks, Biophysics Section, Department of Biological Sciences, The Blackett Laboratory, Imperial College London, London SW7 2AZ, United Kingdom. E-mail: n.franks{at}imperial.ac.uk
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: January 2004 to September 2023

AbstractFullPdf
Jan 2004696770
Feb 20044712478
Mar 2004329950
Apr 2004186136
May 2004205438
Jun 2004226429
Jul 2004434835
Aug 2004297919
Sep 2004536913
Oct 2004583611
Nov 2004144013
Dec 2004183012
Jan 2005336727
Feb 2005236530
Mar 2005335341
Apr 200517289
May 2005162516
Jun 2005332519
Jul 2005183613
Aug 200513268
Sep 200573117
Oct 2005215032
Nov 2005184727
Dec 2005163616
Jan 200620348
Feb 2006173322
Mar 2006163923
Apr 2006152420
May 200611249
Jun 200661810
Jul 2006132312
Aug 20063115
Sep 200661415
Oct 2006101722
Nov 200672923
Dec 200641212
Jan 200741610
Feb 200731515
Mar 2007182932
Apr 200793417
May 200772513
Jun 20076148
Jul 20071146
Aug 200732110
Sep 200781815
Oct 2007122020
Nov 200771614
Dec 200771814
Jan 20085146
Feb 2008391214
Mar 2008381111
Apr 2008552613
May 2008151111
Jun 2008131917
Jul 200811118
Aug 200812209
Sep 200815177
Oct 2008152612
Nov 2008112410
Dec 2008121711
Jan 2009386
Feb 2009101711
Mar 2009242618
Apr 2009141422
May 2009151888
Jun 20098129
Jul 2009121512
Aug 20091487
Sep 2009152118
Oct 2009181011
Nov 20091348
Dec 20091126
Jan 2010101213
Feb 201024411
Mar 2010173212
Apr 2010142014
May 201052610
Jun 201071412
Jul 201026117
Aug 20108915
Sep 20105135
Oct 2010112420
Nov 2010111915
Dec 201082619
Jan 2011111413
Feb 2011163728
Mar 201192216
Apr 2011101614
May 2011122111
Jun 201112912
Jul 2011211016
Aug 201181014
Sep 201115169
Oct 2011201621
Nov 2011192216
Dec 2011152012
Jan 2012192312
Feb 2012183052
Mar 2012353930
Apr 2012243221
May 2012182317
Jun 2012111311
Jul 2012133815
Aug 2012154312
Sep 2012124112
Oct 2012225427
Nov 2012394021
Dec 2012243213
Jan 2013255017
Feb 2013454316
Mar 2013334018
Apr 2013336222
May 201315378
Jun 2013152017
Jul 201382217
Aug 2013182914
Sep 2013132715
Oct 2013253215
Nov 2013203314
Dec 2013233021
Jan 201421186
Feb 2014192611
Mar 20149348
Apr 2014184023
May 2014162510
Jun 2014202637
Jul 201424258
Aug 201416379
Sep 2014134413
Oct 20144113816
Nov 2014327717
Dec 2014328013
Jan 201519507
Feb 2015204511
Mar 2015244311
Apr 201525497
May 2015262516
Jun 2015412715
Jul 2015253012
Aug 2015362810
Sep 201541409
Oct 2015493729
Nov 2015433114
Dec 2015373017
Jan 2016372811
Feb 201646235
Mar 2016341717
Apr 201629168
May 2016203011
Jun 2016263915
Jul 2016222324
Aug 2016242424
Sep 2016173021
Oct 2016116614
Nov 201619486
Dec 20161517225
Jan 201749234
Feb 2017109731
Mar 201765013
Apr 201783311
May 201775819
Jun 201774113
Jul 201712538
Aug 20176382
Sep 201712378
Oct 201712447
Nov 201766414
Dec 201784913
Jan 201885621
Feb 201883715
Mar 2018114314
Apr 20188619
May 201877412
Jun 201867210
Jul 201869223
Aug 20184388
Sep 20186397
Oct 201865710
Nov 2018154514
Dec 20182771
Jan 20192253
Feb 20193230
Mar 201945112
Apr 20195353
May 20194230
Jun 20192623
Jul 20191600
Aug 20193731
Sep 20191911
Oct 20192232
Nov 20193841
Dec 20195223
Jan 20208873
Feb 20207532
Mar 20203711
Apr 20205341
May 20207511
Jun 202059104
Jul 20203010
Aug 20201701
Sep 20207700
Oct 20204632
Nov 20205510
Dec 20204133
Jan 20215383
Feb 20215075
Mar 20216085
Apr 20217653
May 20212652
Jun 20219131
Jul 20217273
Aug 202121102
Sep 20212831
Oct 20212320
Nov 20214075
Dec 20213330
Jan 202279510
Feb 20226621
Mar 20224980
Apr 20227081
May 20223210
Jun 20226473
Jul 20223010
Aug 20225551
Sep 20224920
Oct 20225773
Nov 20223121
Dec 20222431
Jan 202380265
Feb 20232931
Mar 20236582
Apr 20232262
May 20232220
Jun 20236442
Jul 20234020
Aug 20232941
Sep 20231743

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 65 (2)
Molecular Pharmacology
Vol. 65, Issue 2
1 Feb 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Two-Pore-Domain K+ Channels Are a Novel Target for the Anesthetic Gases Xenon, Nitrous Oxide, and Cyclopropane
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Two-Pore-Domain K+ Channels Are a Novel Target for the Anesthetic Gases Xenon, Nitrous Oxide, and Cyclopropane

Marco Gruss, Trevor J. Bushell, Damian P. Bright, William R. Lieb, Alistair Mathie and Nicholas P. Franks
Molecular Pharmacology February 1, 2004, 65 (2) 443-452; DOI: https://doi.org/10.1124/mol.65.2.443

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Two-Pore-Domain K+ Channels Are a Novel Target for the Anesthetic Gases Xenon, Nitrous Oxide, and Cyclopropane

Marco Gruss, Trevor J. Bushell, Damian P. Bright, William R. Lieb, Alistair Mathie and Nicholas P. Franks
Molecular Pharmacology February 1, 2004, 65 (2) 443-452; DOI: https://doi.org/10.1124/mol.65.2.443
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Analgesic Effects and Mechanisms of Licochalcones
  • Induced Fit Ligand Binding to CYP3A4
  • Englerin A Inhibits T-Type Channels
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics